David Hallal Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
Get free email notifications about insider trading for David Hallal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hallal. David Hallal is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Operating Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm. Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP Commercial Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commerical Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Seer, Inc. ($SEER) and Director in Scholar Rock Holding Corp ($SRRK) and Chief Executive Officer in Allovir, Inc. ($ALVR) and Director in iTeos Therapeutics, Inc. ($ITOS).
David Hallal in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Hallal: CEO, Chief Operating Officer, EVP, Chief Commercial Officer, EVP. Global Commercial Ops, SVP. Global Commercial Ops, SVP, Global Commerical Ops, SVP, Global Commercial Ops, SVP Commercial Ops, Americas, Sr. VP Comm Ops, Americas, Sr. VP Comm. Ops, America
Holdings: 189,266 shares
Current Value: $24,173,054
Latest Transaction: Aug 10 2016
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Hallal in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, ALVR, ITOS, SRRK, SEER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 10 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 137.14 | 332 | 45,530 | 189,266 | 189.6 K to 189.3 K (-0.18 %) |
Apr 05 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 136.21 | 34 | 4,631 | 189,598 | 189.6 K to 189.6 K (-0.02 %) |
Apr 05 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 135.87 | 1,380 | 187,501 | 189,632 | 191 K to 189.6 K (-0.72 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Option Exercise | A | 140.16 | 131,000 | 18,360,960 | 131,000 | |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 141.45 | 14 | 1,980 | 191,012 | 191 K to 191 K (-0.01 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.91 | 2,000 | 277,820 | 191,026 | 193 K to 191 K (-1.04 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 20,000 | 0 | 193,026 | 173 K to 193 K (+11.56 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.02 | 3,492 | 481,966 | 173,026 | 176.5 K to 173 K (-1.98 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 139.18 | 117 | 16,284 | 176,518 | 176.6 K to 176.5 K (-0.07 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.02 | 337 | 46,513 | 176,635 | 177 K to 176.6 K (-0.19 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 140.49 | 1,490 | 209,330 | 176,972 | 178.5 K to 177 K (-0.83 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 141.40 | 3,710 | 524,594 | 178,462 | 182.2 K to 178.5 K (-2.04 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 142.35 | 712 | 101,353 | 182,172 | 182.9 K to 182.2 K (-0.39 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 143.45 | 300 | 43,035 | 182,884 | 183.2 K to 182.9 K (-0.16 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 144.45 | 400 | 57,780 | 183,184 | 183.6 K to 183.2 K (-0.22 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 145.01 | 110 | 15,951 | 183,584 | 183.7 K to 183.6 K (-0.06 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 41,136 | 0 | 183,694 | 142.6 K to 183.7 K (+28.86 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 145.05 | 10 | 1,451 | 142,558 | 142.6 K to 142.6 K (-0.01 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 143.81 | 619 | 89,018 | 142,568 | 143.2 K to 142.6 K (-0.43 %) |
Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 190.01 | 329 | 62,513 | 143,187 | 143.5 K to 143.2 K (-0.23 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 196.52 | 612 | 120,270 | 143,516 | 144.1 K to 143.5 K (-0.42 %) |
Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Option Exercise | A | 173.30 | 49,275 | 8,539,358 | 49,275 | |
Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 11,270 | 0 | 144,128 | 132.9 K to 144.1 K (+8.48 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 7,626 | 1,375,502 | 7,626 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 32,200 | 5,807,914 | 32,200 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 180.34 | 730 | 131,648 | 132,858 | 133.6 K to 132.9 K (-0.55 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 2,265 | 0 | 133,588 | 131.3 K to 133.6 K (+1.72 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 7,290 | 0 | 131,323 | 124 K to 131.3 K (+5.88 %) |
Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 171.15 | 1,980 | 338,877 | 124,033 | 126 K to 124 K (-1.57 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 173.93 | 2,920 | 507,876 | 126,013 | 128.9 K to 126 K (-2.26 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 11,690 | 0 | 128,933 | 117.2 K to 128.9 K (+9.97 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.38 | 608 | 106,023 | 117,243 | 117.9 K to 117.2 K (-0.52 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.02 | 765 | 133,125 | 117,851 | 118.6 K to 117.9 K (-0.64 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 182.03 | 5,494 | 1,000,073 | 113,122 | 118.6 K to 113.1 K (-4.63 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 17.65 | 14,336 | 253,030 | 0 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 22.90 | 15,664 | 358,706 | 84,336 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.02 | 14,336 | 2,724,127 | 118,616 | 133 K to 118.6 K (-10.78 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.00 | 15,664 | 2,976,160 | 132,952 | 148.6 K to 133 K (-10.54 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 17.65 | 14,336 | 253,030 | 148,616 | 134.3 K to 148.6 K (+10.68 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 22.90 | 15,664 | 358,706 | 134,280 | 118.6 K to 134.3 K (+13.21 %) |
Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 158.00 | 1,349 | 213,142 | 118,616 | 120 K to 118.6 K (-1.12 %) |
Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,000 | 0 | 119,965 | 114 K to 120 K (+5.26 %) |
Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 158.05 | 10 | 1,581 | 113,965 | 114 K to 114 K (-0.01 %) |
Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 156.95 | 10 | 1,570 | 113,965 | 114 K to 114 K (-0.01 %) |
Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 155.55 | 1,600 | 248,880 | 113,975 | 115.6 K to 114 K (-1.38 %) |
Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 9,745 | 0 | 115,575 | 105.8 K to 115.6 K (+9.21 %) |
Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 153.63 | 2,390 | 367,176 | 105,830 | 108.2 K to 105.8 K (-2.21 %) |
Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 157.14 | 729 | 114,555 | 108,220 | 108.9 K to 108.2 K (-0.67 %) |
Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 133.37 | 29 | 3,868 | 108,949 | 109 K to 108.9 K (-0.03 %) |
Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 133.45 | 700 | 93,415 | 108,978 | 109.7 K to 109 K (-0.64 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 15,363 | 276,227 | 0 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 7,295 | 131,128 | 0 | |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.61 | 15,363 | 1,960,472 | 109,678 | 125 K to 109.7 K (-12.29 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 17.98 | 15,363 | 276,227 | 125,041 | 109.7 K to 125 K (+14.01 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.53 | 7,295 | 930,331 | 109,678 | 117 K to 109.7 K (-6.24 %) |
Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 7,295 | 131,164 | 116,973 | 109.7 K to 117 K (+6.65 %) |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 14,637 | 263,173 | 15,363 | |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 10,705 | 192,422 | 7,295 | |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.63 | 14,637 | 1,868,120 | 109,678 | 124.3 K to 109.7 K (-11.77 %) |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 14,637 | 263,173 | 124,315 | 109.7 K to 124.3 K (+13.35 %) |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.63 | 10,705 | 1,366,279 | 109,678 | 120.4 K to 109.7 K (-8.89 %) |
Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 10,705 | 192,476 | 120,383 | 109.7 K to 120.4 K (+9.76 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 18,000 | 323,550 | 18,000 | |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 123.77 | 7,963 | 985,581 | 88,178 | 96.1 K to 88.2 K (-8.28 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 122.79 | 22,037 | 2,705,923 | 96,141 | 118.2 K to 96.1 K (-18.65 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 30,000 | 539,400 | 118,178 | 88.2 K to 118.2 K (+34.02 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 123.77 | 4,777 | 591,249 | 88,178 | 93 K to 88.2 K (-5.14 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 122.79 | 13,223 | 1,623,652 | 92,955 | 106.2 K to 93 K (-12.45 %) |
Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 18,000 | 323,640 | 106,178 | 88.2 K to 106.2 K (+20.41 %) |
Aug 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 116.87 | 730 | 85,315 | 88,178 | 88.9 K to 88.2 K (-0.82 %) |
Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 110.86 | 746 | 82,702 | 88,908 | 89.7 K to 88.9 K (-0.83 %) |
Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.65 | 50,000 | 882,500 | 14,336 | |
Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 120.00 | 50,000 | 6,000,000 | 89,654 | 139.7 K to 89.7 K (-35.80 %) |
Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.65 | 50,000 | 882,500 | 139,654 | 89.7 K to 139.7 K (+55.77 %) |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.65 | 5,664 | 99,970 | 0 | |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 11.92 | 5,692 | 67,849 | 0 | |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 10.29 | 3,128 | 32,187 | 0 | |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 8.16 | 524 | 4,276 | 0 | |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.65 | 5,664 | 99,970 | 89,654 | 84 K to 89.7 K (+6.74 %) |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 11.92 | 5,692 | 67,849 | 83,990 | 78.3 K to 84 K (+7.27 %) |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 10.29 | 3,128 | 32,187 | 78,298 | 75.2 K to 78.3 K (+4.16 %) |
Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 8.16 | 524 | 4,276 | 75,170 | 74.6 K to 75.2 K (+0.70 %) |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | A | 93.83 | 73,000 | 6,849,590 | 73,000 | |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 5,400 | 0 | 74,646 | 69.2 K to 74.6 K (+7.80 %) |
Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 96.74 | 985 | 95,289 | 69,246 | 70.2 K to 69.2 K (-1.40 %) |
Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 95.68 | 1,100 | 105,248 | 70,231 | 71.3 K to 70.2 K (-1.54 %) |
Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP. Global Commerc ... | Sell | S | 94.32 | 512 | 48,292 | 71,331 | 71.8 K to 71.3 K (-0.71 %) |
Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP. Global Commerc ... | Sell | S | 94.50 | 632 | 59,724 | 71,843 | 72.5 K to 71.8 K (-0.87 %) |
Oct 26 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 8.16 | 10,500 | 85,680 | 524 | |
Oct 26 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 8.16 | 10,500 | 85,680 | 72,475 | 62 K to 72.5 K (+16.94 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 17.65 | 50,000 | 882,500 | 64,336 | |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 104.99 | 680 | 71,393 | 61,975 | 62.7 K to 62 K (-1.09 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 106.14 | 555 | 58,908 | 62,655 | 63.2 K to 62.7 K (-0.88 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 107.74 | 50,000 | 5,387,000 | 63,210 | 113.2 K to 63.2 K (-44.17 %) |
Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 17.65 | 50,000 | 882,500 | 113,210 | 63.2 K to 113.2 K (+79.10 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 14,308 | 170,551 | 0 | |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 93.67 | 14,308 | 1,340,230 | 63,210 | 77.5 K to 63.2 K (-18.46 %) |
Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 14,308 | 170,551 | 77,518 | 63.2 K to 77.5 K (+22.64 %) |
May 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 10,000 | 81,600 | 84,710 | |
May 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 10,000 | 81,600 | 63,210 | 53.2 K to 63.2 K (+18.79 %) |
Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 40,000 | 476,800 | 14,308 | |
Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 85.50 | 40,000 | 3,420,000 | 53,210 | 93.2 K to 53.2 K (-42.91 %) |
Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 40,000 | 476,800 | 93,210 | 53.2 K to 93.2 K (+75.17 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 78.88 | 77,000 | 6,073,760 | 77,000 | |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 0.00 | 10,000 | 0 | 53,210 | 43.2 K to 53.2 K (+23.14 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 74.51 | 1,896 | 141,271 | 39,749 | 41.6 K to 39.7 K (-4.55 %) |
Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 74.41 | 554 | 41,223 | 41,645 | 42.2 K to 41.6 K (-1.31 %) |
Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 75.00 | 536 | 40,200 | 42,199 | 42.7 K to 42.2 K (-1.25 %) |
Jan 04 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 3,000 | 24,480 | 21,024 | |
Jan 04 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 3,000 | 24,480 | 42,735 | 39.7 K to 42.7 K (+7.55 %) |
Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 20,000 | 238,400 | 54,308 | |
Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 66.59 | 20,000 | 1,331,800 | 39,735 | 59.7 K to 39.7 K (-33.48 %) |
Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 20,000 | 238,400 | 59,735 | 39.7 K to 59.7 K (+50.33 %) |
Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 5,000 | 40,800 | 24,024 | |
Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 5,000 | 40,800 | 29,024 | |
Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 5,000 | 40,800 | 39,735 | 34.7 K to 39.7 K (+14.39 %) |
Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 5,000 | 40,800 | 34,735 | 29.7 K to 34.7 K (+16.82 %) |
Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 10.29 | 36,872 | 379,413 | 0 | |
Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 57.33 | 36,872 | 2,113,872 | 29,735 | 66.6 K to 29.7 K (-55.36 %) |
Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 10.29 | 36,872 | 379,413 | 66,607 | 29.7 K to 66.6 K (+124.00 %) |
Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 57.27 | 555 | 31,785 | 29,735 | 30.3 K to 29.7 K (-1.83 %) |
Jul 12 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 50.00 | 501 | 25,050 | 30,290 | 30.8 K to 30.3 K (-1.63 %) |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | S | 20.58 | 4,900 | 100,842 | 18,436 | |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | S | 20.58 | 100 | 2,058 | 23,336 | |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 99.21 | 4,900 | 486,129 | 15,646 | 20.5 K to 15.6 K (-23.85 %) |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 20.58 | 4,900 | 100,842 | 20,546 | 15.6 K to 20.5 K (+31.32 %) |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 100.00 | 100 | 10,000 | 15,646 | 15.7 K to 15.6 K (-0.64 %) |
Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 20.58 | 100 | 2,058 | 15,746 | 15.6 K to 15.7 K (+0.64 %) |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | A | 85.31 | 50,000 | 4,265,500 | 50,000 | |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Grant | A | 0.00 | 6,000 | 0 | 15,646 | 9.6 K to 15.6 K (+62.20 %) |
Jan 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commeri ... | Sell | S | 84.70 | 1,110 | 94,017 | 9,646 | 10.8 K to 9.6 K (-10.32 %) |
Jan 18 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 82.66 | 245 | 20,252 | 10,756 | 11 K to 10.8 K (-2.23 %) |
Jan 12 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 81.27 | 269 | 21,862 | 11,001 | 11.3 K to 11 K (-2.39 %) |
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 13,616 | 222,213 | 19,512 | |
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 79.33 | 13,616 | 1,080,157 | 8,770 | 22.4 K to 8.8 K (-60.82 %) |
Dec 29 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 13,616 | 222,213 | 22,386 | 8.8 K to 22.4 K (+155.26 %) |
Dec 28 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 2,500 | 40,800 | 30,628 | |
Dec 28 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 2,500 | 40,800 | 11,270 | 8.8 K to 11.3 K (+28.51 %) |
Dec 15 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 5,000 | 81,600 | 33,128 | |
Dec 15 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 5,000 | 81,600 | 8,770 | 3.8 K to 8.8 K (+132.63 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 20,000 | 326,400 | 13,616 | |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.29 | 20,000 | 1,405,800 | 3,770 | 23.8 K to 3.8 K (-84.14 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Buy | M | 16.32 | 20,000 | 326,400 | 23,770 | 3.8 K to 23.8 K (+530.50 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.42 | 1,000 | 70,420 | 3,770 | 4.8 K to 3.8 K (-20.96 %) |
Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 70.43 | 1,619 | 114,026 | 4,770 | 6.4 K to 4.8 K (-25.34 %) |
Jul 19 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.08 | 227 | 11,595 | 6,389 | 6.6 K to 6.4 K (-3.43 %) |
Jul 13 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 51.91 | 238 | 12,355 | 6,616 | 6.9 K to 6.6 K (-3.47 %) |
Jun 21 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Sell | S | 54.81 | 916 | 50,206 | 6,854 | 7.8 K to 6.9 K (-11.79 %) |
Mar 04 2010 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP Commercial Ops, ... | Option Exercise | S | 16.32 | 10,000 | 163,200 | 58,128 |